Acute Sinusitis Clinical Presentation
- Author: Itzhak Brook, MD, MSc; Chief Editor: Burke A Cunha, MD more...
History
Acute sinusitis is a clinical diagnosis; thus, an understanding of its presentation is of paramount importance in differentiating this entity from allergic or vasomotor rhinitis and common upper respiratory infections. No specific clinical symptom or sign is sensitive or specific for acute sinusitis, so the overall clinical impression should be used to guide management.
A history of occupational or allergic rhinitis, vasomotor rhinitis, nasal polyps, rhinitis medicamentosa, or immunodeficiency should be sought in an evaluation for rhinosinusitis. Rhinosinusitis is more common in individuals with congenital defects that affect humoral immunity and ciliary motility, in those with cystic fibrosis, and in persons with AIDS.
Obtain a history of diabetes or organ transplant if invasive fungal sinusitis is being considered. Fungal infections are more common in people with diabetes and those who are immunocompromised. Clinicians should maintain a high index of suspicion for acute invasive fungal sinusitis in immunocompromised patients with orbital or CNS complications of rhinosinusitis.
Clinical findings may include the following:
- Pain over cheek and radiating to frontal region or teeth, increasing with straining or bending down
- Redness of nose, cheeks, or eyelids
- Tenderness to pressure over the floor of the frontal sinus immediately above the inner canthus
- Referred pain to the vertex, temple, or occiput
- Postnasal discharge
- A blocked nose
- Persistent coughing or pharyngeal irritation
- Facial pain
- Hyposmia
The duration of the condition should be determined. Suspect acute sinusitis in any patient with an upper respiratory tract infection that persists beyond 7-10 days, particularly if the infection is severe and is accompanied by high fever, purulent nasal discharge, or periorbital edema (ethmoid sinusitis).
The condition may start as an upper respiratory tract infection, and the patient may seem to be recovering; however, the condition becomes acutely worse around the seventh day of illness. This should be considered a red flag because most upper respiratory tract infections last 5-7 days. The natural history of rhinovirus infection, as described by Gwaltney et al, lasts from 1-33 days. One fourth of patients have symptoms that last longer than 14 days.[27]
Bacterial and viral sinusitis
During the course of a viral upper respiratory tract infection, 3 three common clinical presentations should prompt the clinician to consider that the patient is experiencing an episode of acute bacterial sinusitis. These presentations are described as onset with persistent symptoms, onset with severe symptoms, or onset with worsening symptoms. What is meant by persistent symptoms, in the context of acute bacterial sinusitis, is respiratory symptoms that last more than 10 days but less than 30 days and which have not begun to improve. Such symptoms include nasal discharge (of any quality, eg, thick or thin, serous, mucoid or purulent) or daytime cough (which may be worse at night) or both.
A consensus statement published in Otolaryngology-Head and Neck Surgery made strong recommendations that clinicians should distinguish between acute rhinosinusitis caused by bacterial causes and those episodes caused by viral upper respiratory infections and noninfectious conditions.[28]
The panel suggests that the diagnosis of acute bacterial sinusitis be entertained when (1) symptoms or signs of acute rhinosinusitis are present 10 days or more beyond the onset of upper respiratory symptoms, or (2) symptoms or signs of acute rhinosinusitis worsen within 10 days after an initial improvement. A history of purulent secretions and facial or dental pain are specific symptoms that may point to a bacterial etiology. In a patient in intensive care, acute sinusitis should be suspected in the presence of sepsis of unknown origin.
The consensus statement is in accordance with the AAAAI 2005 practice parameter for diagnosis and management of sinusitis, which states that upper respiratory tract infections persisting after 10-14 days are suspicious for acute bacterial sinusitis. The likelihood of bacterial disease increases if the infection history includes persistent purulent rhinorrhea, postnasal drainage, and facial pain.[12]
Acute bacterial rhinosinusitis is commonly overdiagnosed. In fact, acute bacterial rhinosinusitis is the correct diagnosis in only 40-50% of cases in which a primary care physician initially classifies a patient as likely having the condition.[29]
Although diagnostic criteria for acute rhinosinusitis have been proposed,[1] no single sign or symptom has strong diagnostic value for bacterial rhinosinusitis.[30] As noted, however, acute bacterial rhinosinusitis should be suspected in patients who exhibit symptoms of viral upper respiratory tract infection that do not improve after 10 days or that worsen after 5-7 days.
Symptoms of acute bacterial rhinosinusitis include the following:
- Facial pain or pressure (especially unilateral)
- Hyposmia/anosmia
- Nasal congestion
- Nasal drainage
- Postnasal drip
- Fever
- Cough
- Fatigue
- Maxillary dental pain
- Ear fullness/pressure
A change in the color or characteristic of the nasal discharge is not a specific sign of bacterial rhinosinusitis. A previous diagnosis of rhinosinusitis is not a predictor of acute bacterial rhinosinusitis.[30]
Physical Examination
Anterior rhinoscopic examination, with or without a topical decongestant, is important to assess the status of the nasal mucosa and the presence and color of nasal discharge. Predisposing anatomical variations can also be noted during anterior rhinoscopy.
Endoscopic examination may reveal the origin of the purulent discharge from the middle meatus and may provide information about the nature of ostiomeatal obstruction. The use of endoscopy may also aid in the etiologic diagnosis of acute sinusitis by allowing the careful attainment of purulent secretions from the sinus ostia for culture. Purulent secretions in the middle meatus (highly predictive of maxillary sinusitis) may be seen using a nasal speculum and a directed light.
Fever is seen in fewer than 2% of individuals with sinusitis. Sinus transillumination and palpation are of little predictive value. Facial tenderness to palpation is present. Complete opacification of maxillary or frontal sinuses may be seen on transillumination; partial opacification is a nonspecific finding, and it is not as reliable. A basic evaluation of ocular and neurological function is also necessary to rule out potential complications.
The following may be noted:
- Purulent nasal secretions
- Purulent posterior pharyngeal secretions
- Mucosal erythema
- Periorbital edema
- Tenderness overlying sinuses
- Air-fluid levels on transillumination of the sinuses (60% reproducibility rate for assessing maxillary sinus disease)
- Facial erythema
Evaluation of the pediatric patient
Sinusitis and upper respiratory tract infections are common pediatric problems. As many as 10% of upper respiratory tract infections can be complicated by acute sinusitis. Untreated chronic sinusitis can lead to life-threatening complications.
Physical examination findings may not be helpful in making a diagnosis of acute bacterial sinusitis in a child because the findings are almost identical to those of a child with viral rhinosinusitis. The presence of pus in the middle meatus suggests involvement of maxillary, frontal, or ethmoid sinuses; pus in the superior meatus suggests involvement of sphenoid or posterior ethmoid cells.
According to a study by Mcquillan et al in which pediatricians were asked how they diagnose and manage nonsevere acute sinusitis in children, on the basis of age group, pediatricians reported first considering acute sinusitis at the following rates: ages 0-5 (6%), 6-11 (17%), 12-23 (36%), 24-35 (21%), and 36 months or older (20%).[31]
In the Mcquillan study, symptoms thought to be very important included prolonged symptom duration (93%), purulent rhinorrhea (55%), and nasal congestion (43%); 60% reported that symptom duration is more important than symptom combination. Symptom duration before considering the diagnosis were 1-6 days (3%), 7-9 days (17%), 10-13 days (37%), 14-16 days (38%), and 17 or more days (6%).
Mcquillan et al reported that CT scanning was used by 58% in making the diagnosis of acute sinusitis. Antibiotics were used frequently or always by 96% of the respondents. Adjuvants used frequently or always included saline washes (44%), systemic decongestants (28%), nasal corticosteroids (20%), and systemic antihistamines (13%).
In children younger than 6 years, the nasal examination usually consists of evaluating the anterior nasal cavity and middle meatus with anterior rhinoscopy using an otoscope and ear speculum. The superior meatus can never be observed with this technique and is difficult to observe with nasal endoscopy, rigid rhinoscopy, or both. Purulence running into the posterior nasal cavity and nasopharynx, observed only by rigid rhinoscopy, can indicate probable drainage from the sphenoethmoid recess, which drains the posterior ethmoids and sphenoid sinuses.
In persons with acute ethmoiditis, especially in infants and younger children, periorbital cellulitis with edema of the soft tissues and erythema of the overlying skin is not uncommon.
American Academy of Pediatrics (AAP) recommendations do not require imaging in the diagnosis of children aged 6 years or younger to make the diagnosis of uncomplicated acute bacterial sinusitis if they meet the criteria for the diagnosis.
Complications of Disease
Approximately 75% of orbital or periorbital infections are the result of extending sinusitis. Untreated, inadequately treated, or partially treated rhinosinusitis may lead to chronic rhinosinusitis, meningitis, brain abscess, or other extra-sinus complications. (See Treatment and Management.)
Local complications
Mucoceles are chronic epithelial cysts that develop in sinuses in the presence of either an obstructed sinus ostium or minor salivary gland duct. They have the potential for progressive concentric expansion that can lead to bony erosion and extension beyond the sinus.
Maxillary sinus mucoceles are usually found incidentally on sinus radiographs and are of little significance in the absence of symptomatology or infection. Frontoethmoidal and sphenoethmoidal mucoceles, on the other hand, tend to be symptomatic and have a high potential for bony erosion.
Osteomyelitis is a potential local complication most commonly occurring with frontal sinusitis. Osteomyelitis of the frontal bone is called a Pott puffy tumor and represents a subperiosteal abscess with local edema anterior to the frontal sinus. This can advance to form a fistula to the upper lid with sequestration of necrotic bone.
Orbital complications
Orbital complications are the most common complications encountered with acute bacterial sinusitis. Infection can spread directly through the thin bone separating the ethmoid or frontal sinuses from the orbit or by thrombophlebitis of the ethmoid veins.
Diagnosis should be based on an accurate physical examination, including ophthalmological evaluation and appropriate radiological studies. CT scanning is the most sensitive means of diagnosing an orbital abscess, although ultrasound has been found to be 90% effective for diagnosing anterior abscesses.[27] The classification by Chandler, which is based on physical examination findings, provides a reasonable framework to guide management. This classification consists of 5 groups of orbital inflammation[30] :
- Group 1 - Inflammatory edema (preseptal cellulitis) with normal visual acuity and extraocular movement
- Group 2 - Orbital cellulitis with diffuse orbital edema but no discrete abscess
- Group 3 - Subperiosteal abscess beneath the periosteum of the lamina papyracea resulting in downward and lateral globe displacement
- Group 4 - Orbital abscess with chemosis, ophthalmoplegia, and decreased visual acuity
- Group 5 - Cavernous sinus thrombosis with rapidly progressive bilateral chemosis, ophthalmoplegia, retinal engorgement, and loss of visual acuity; possible meningeal signs and high fever
Intracranial complications
Intracranial complications may occur as a result of direct extension through the posterior frontal sinus wall or through retrograde thrombophlebitis of the ophthalmic veins. Subdural abscess is the most common intracranial complication, although cerebral abscesses and infarction that result in seizures, focal neurological deficits, and coma may occur.
Systemic complications
Sinusitis can result in sepsis and multisystem organ failure caused by seeding of the blood and various organ systems. Reports of bacteremia, thoracic empyema, and nosocomial pneumonia have been documented in the intensive-care population with acute sinusitis, and the mortality rate in this group can be as high as 11%.
Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. Sep 1997;117(3 Pt 2):S1-7. [Medline].
American Academy of Pediatrics - Subcommittee on Management of Sinusitis and Committee on Quality Management. Clinical practice guideline: management of sinusitis. Pediatrics. Sep 2001;108(3):798-808. [Medline].
Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. Dec 2004;131(6 Suppl):S1-62. [Medline].
Stark JM, Colasurdo GN. Lung Defense: intrinsic, innate and adaptive. In: Chernick V, Boat TF, Wilmott RW, Bush A, eds. Kendig's Disorders of the Respiratory Tract in Children. Vol. 12. 7th Ed. Philadelphia, PA: Saunders Elsevier; 2006:206.
Cherry JD, Shapiro NL, Deville JG. Sinusitis. In: Feigin RD, Cherry JD, Demmier GJ, Kaplan SL, eds. Textbook of pediatric infectious disease. 5th ed. Philadelphia, PA: WB Saunders; 2004:201.
Brook I. Aerobic and anaerobic bacterial flora of normal maxillary sinuses. Laryngoscope. Mar 1981;91(3):372-6. [Medline].
Su WY, Liu C, Hung SY, Tsai WF. Bacteriological study in chronic maxillary sinusitis. Laryngoscope. Jul 1983;93(7):931-4. [Medline].
Sobin J, Engquist S, Nord CE. Bacteriology of the maxillary sinus in healthy volunteers. Scand J Infect Dis. 1992;24(5):633-5. [Medline].
Jiang RS, Liang KL, Jang JW, Hsu CY. Bacteriology of endoscopically normal maxillary sinuses. J Laryngol Otol. Sep 1999;113(9):825-8. [Medline].
Gordts F, Halewyck S, Pierard D, Kaufman L, Clement PA. Microbiology of the middle meatus: a comparison between normal adults and children. J Laryngol Otol. Mar 2000;114(3):184-8. [Medline].
Hamilos DL. Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis. UpToDate. Available at http://www.uptodate.com. Accessed June 7th, 2009.
Slavin RG, Spector SL, Bernstein IL, Kaliner MA, Kennedy DW, Virant FS, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. Dec 2005;116(6 Suppl):S13-47. [Medline]. [Full Text].
Ah-See K. Sinusitis (acute). Clin Evid (Online). Mar 10 2008;2008:[Medline].
Hwang PH, Getz A. Acute sinusitis and rhinosinusitis in adults. UpToDate. Available at http://www.uptodate.com. Accessed June 7th, 2009.
Revai K, Dobbs LA, Nair S, Patel JA, Grady JJ, Chonmaitree T. Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age. Pediatrics. Jun 2007;119(6):e1408-12. [Medline].
Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis. Dec 1996;23(6):1209-23; quiz 1224-5. [Medline].
Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol. Jul 2006;55:943-6. [Medline].
Brook I, Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol. Apr 2007;71(4):575-9. [Medline].
Jacobs MR, Bajaksouzian S, Windau A, Good CE, Lin G, Pankuch GA, et al. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study. Clin Lab Med. Jun 2004;24(2):503-30. [Medline].
Payne SC, Benninger MS. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis. Nov 15 2007;45(10):e121-7. [Medline].
Brook I, Foote PA, Hausfeld JN. Increase in the frequency of recovery of meticillin-resistant Staphylococcus aureus in acute and chronic maxillary sinusitis. J Med Microbiol. Aug 2008;57:1015-7. [Medline].
Lucas JW, Schiller JS, Benson V. Summary health statistics for U.S. adults: National Health Interview Survey, 2001. Vital Health Stat 10. Jan 2004;1-134. [Medline].
Bishai WR. Issues in the management of bacterial sinusitis. Otolaryngol Head Neck Surg. Dec 2002;127(6 Suppl):S3-9. [Medline].
Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol. Mar 1999;103(3 Pt 1):408-14. [Medline].
Fendrick AM, Saint S, Brook I, Jacobs MR, Pelton S, Sethi S. Diagnosis and treatment of upper respiratory tract infections in the primary care setting. Clin Ther. Oct 2001;23(10):1683-706. [Medline].
Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. Feb 1991;87(2):129-33. [Medline].
Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. Nov 6 1967;202(6):494-500. [Medline].
[Guideline] Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. Sep 2007;137(3 Suppl):S1-31. [Medline].
Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ. Jul 22 1995;311(6999):233-6. [Medline]. [Full Text].
Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. Mar 20 2001;134(6):498-505. [Medline].
McQuillan L, Crane LA, Kempe A. Diagnosis and management of acute sinusitis by pediatricians. Pediatrics. Feb 2009;123(2):e193-8. [Medline].
Savolainen S, Jousimies-Somer H, Karjalainen J, Ylikoski J. Do simple laboratory tests help in etiologic diagnosis in acute maxillary sinusitis?. Acta Otolaryngol Suppl. 1997;529:144-7. [Medline].
Lusk RP, Stankiewicz JA. Pediatric rhinosinusitis. Otolaryngol Head Neck Surg. Sep 1997;117(3 Pt 2):S53-7. [Medline].
Gordts F, Abu Nasser I, Clement PA, Pierard D, Kaufman L. Bacteriology of the middle meatus in children. Int J Pediatr Otorhinolaryngol. May 5 1999;48(2):163-7. [Medline].
[Best Evidence] Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database Syst Rev. Apr 18 2007;CD005149. [Medline].
[Best Evidence] Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA. Dec 5 2007;298(21):2487-96. [Medline].
[Best Evidence] Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi UM, Williams JW Jr, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. Apr 16 2008;CD000243. [Medline].
Young J, De Sutter A, Merenstein D, van Essen GA, Kaiser L, Varonen H, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet. Mar 15 2008;371(9616):908-14. [Medline].
Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA. Feb 15 2012;307(7):685-92. [Medline].
Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis. Apr 2012;54(8):e72-e112. [Medline].
Zalmanovici A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. Oct 7 2009;CD005149. [Medline].
Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis. Sep 2008;8(9):543-52. [Medline].
National Guidelines Clearinghouse. Clinical practice guideline: adult sinusitis. National Guidelines Clearinghouse. Available at http://guideline.gov/summary/summary.aspx?doc_id=12385. Accessed September 29, 2010.
Marple BF, Roberts CS, Frytak JR, Schabert VF, Wegner JC, Bhattacharyya H, et al. Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis. Am J Otolaryngol. Jan-Feb 2010;31(1):1-8. [Medline].
Platt MP, Cunnane ME, Curtin HD, Metson R. Anatomical changes of the ethmoid cavity after endoscopic sinus surgery. Laryngoscope. Dec 2008;118(12):2240-4. [Medline].
Huang BY, Lloyd KM, DelGaudio JM, Jablonowski E, Hudgins PA. Failed endoscopic sinus surgery: spectrum of CT findings in the frontal recess. Radiographics. Jan-Feb 2009;29(1):177-95. [Medline].
Hnatuk LA, Macdonald RE, Papsin BC. Isolated sphenoid sinusitis: the Toronto Hospital for Sick Children experience and review of the literature. J Otolaryngol. Feb 1994;23(1):36-41. [Medline].
DelGaudio JM, Evans SH, Sobol SE, Parikh SL. Intracranial complications of sinusitis: what is the role of endoscopic sinus surgery in the acute setting. Am J Otolaryngol. Jan-Feb 2010;31(1):25-8. [Medline].
Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. Jan 2004;130(1 Suppl):1-45. [Medline].
Chan KH, Abzug MJ, Coffinet L, Simoes EA, Cool C, Liu AH. Chronic rhinosinusitis in young children differs from adults: a histopathology study. J Pediatr. Feb 2004;144(2):206-12. [Medline].
| Antibiotic | Dosage | Streptococcus pneumoniae | Haemophilus influenzae | Moraxella catarrhalis | Anaerobic bacteria | ||
| Sensitive | Intermediate | Resistant | |||||
| Amoxicillin | 500 mg PO tid | +++ | ++ | + | ++ | + | +++ (except beta-lactamase producers) |
| Clarithromycin | 250-500 mg PO bid | ++ | ++ | + | ++ | +++ | + |
| Azithromycin | 500 mg PO first day, then 250 mg/d PO for 4 days | ++ | ++ | + | ++ | +++ | + |
| *+, low activity against microorganism; ++, moderate activity against microorganism; +++, good activity against microorganism | |||||||
| Antibiotic | Dosage | Streptococcus pneumoniae | Haemophilus influenzae | Moraxella catarrhalis | Anaerobic bacteria | ||
| Sensitive | Intermediate | Resistant | |||||
| Amoxicillin/ clavulanate | 500 mg PO tid | +++ | ++ | + | +++ | +++ | +++ |
| Cefuroxime | 250-500 mg PO bid | +++ | ++ | + | +++ | ++ | ++ |
| Cefpodoxime + cefixime | 200 mg PO bid 400 mg/d PO | - ++ | +++ - | ++ - | + +++ | +++ +++ | ++ - |
| Ciprofloxacin | 500-750 mg PO bid | ++ | + | + | ++ | +++ | + |
| Levofloxacin | 500 mg/d PO | +++ | +++ | +++ | +++ | +++ | ++ |
| Trovafloxacin | 200 mg/d PO | +++ | +++ | +++ | +++ | +++ | +++ |
| Clindamycin | 300 mg PO tid | +++ | +++ | ++ | - | - | +++ |
| Metronidazole | 500 mg PO tid | - | - | - | - | - | +++ |
| *+, low activity against microorganism; ++, moderate activity against microorganism; +++, good activity against microorganism; -, no activity against microorganism | |||||||
| Antibiotic | Dosage | Streptococcus pneumoniae † | Haemophilus influenzae | Moraxella catarrhalis | Gram-negative | Anaerobic bacteria |
| Piperacillin | 3-4 g IV q4-6h | +++ | + | - | +++ | +++ |
| Piperacillin/tazobactam | 3.375 g IV q6h | +++ | +++ | +++ | +++ | ++ |
| Ticarcillin | 3 g IV q4h | +++ | - | - | +++ | ++ |
| Ticarcillin/clavulanate | 3.1 g IV q4h | +++ | +++ | - | +++ | ++ |
| Imipenem | 500 mg IV q6h | +++ | +++ | +++ | +++ | +++ |
| Meropenem | 1 g IV q8h | +++ | +++ | +++ | +++ | +++ |
| Cefuroxime | 1 g IV q8h | +++ | +++ | +++ | ++ | ++ |
| Ceftriaxone | 2 g IV bid | +++ | +++ | +++ | +++ | ++ |
| Cefotaxime | 2 g IV q4-6h | +++ | +++ | +++ | +++ | ++ |
| Ceftazidime | 2 g IV q8h | +++ | +++ | +++ | +++ | ++ |
| Gentamicin | 1.7 mg/kg IV q8h | - | +++ | +++ | ++ | - |
| Tobramycin | 1.7 mg/kg IV q8h | - | +++ | +++ | ++ | - |
| Vancomycin | 1 g IV q6-12h | +++ | - | - | - | ++ |
| *+, low activity against microorganism; ++, moderate activity against microorganism; +++, good activity against microorganism; -, no activity against microorganism †Does not take into account penicillin-resistant types. | ||||||

